CTRI/2023/11/060046
Not yet recruiting
未知
To study the Safety and Efficacy of classical Ayurvedic treatment in the functional improvements ofpatients with Cervical Spondylitis - Nil
Mprex Healthcare Pvt.Ltd. Wakad, pune0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Mprex Healthcare Pvt.Ltd. Wakad, pune
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Male and female subjects 30\-60 years of age (both inclusive)
- •2\.Subject diagnosed with cervical spondylitis with or without nerve compression for more than three months.
- •3\.Pain in the neck and shoulder, and difficulty with neckline rotation, flexion, extension,etc.
- •4\.Subject have Muscle spasm, Numbness, Tingling sensation, and joint stiffness.
- •5\.Be willing to refrain from taking analgesics, anti\-inflammatory agents, corticosteroids, muscle relaxants, etc. during the entire trial.
- •6\.An ambulatory subject can provide verbal and written consent and is ready to comply with all study procedures.
Exclusion Criteria
- •1\. Patients suffering from a pathological condition like a Bone tumor, Tuberculosis spine, etc.
- •2\. History of injury to the cervical spine with the major surgical intervention will be excluded.
- •3\. Female subjects, who are pregnant, breastfeeding, or planning to become pregnant.
- •4\. Patients who are unable to walk without support and/or confined to a wheelchair or bedridden.
- •5\. History of psychiatric disorder that may impair the ability of subjects to provide written informed consent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
A clinical trial to study the effect of Kutajavaleha in Grahani RogaCTRI/2019/01/017277Central Council for Research in Ayurvedic Sciences New Delhi
Not yet recruiting
Not Applicable
Therapeutic role of Ayurvedic interventions in Amavata(Rheumatoid arthritis) with special reference to gut microbiotaCTRI/2020/10/028746AMRIT GODBOLE
Completed
Phase 2
Clinical trial of CIM-Meg19 in COVID-19 patientsCTRI/2021/05/033543Ms Meghdoot Gramodyog Sewa Sansthan80
Not yet recruiting
Not Applicable
Evaluation of Role of Ayurvedic Drug- Guduchi Ghan Vati in the treatment of COVID-19 related illnessCTRI/2020/05/025370Dr SR Rajasthan Ayurved University Jodhpur
Completed
Phase 3
Effect of Ayurveda intervention AYUSH-64 add-on therapy for patients with COVID-19 infection (Stage I)Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/05/025156Central Council for Research in Ayurvedic Sciences60